drug approval Archives - Oncology Central Oncology Central

i
i

29 Apr 2020 Clinical trials
PROfound trial demonstrates efficacy of olaparib in prostate cancer
5 Mar 2020 Immuno-oncology
Prochlorperazine repurposed: a new use in clustering tumor surface receptors to support immunotherapy
10 Feb 2020 Ask the Experts
Ask the Experts: what are the challenges surrounding biosimilar medicines? (Part II: potential for reinvestment in health and future outlook)
20 Sep 2018
NICE rejects Kymriah® for adults with lymphoma
17 Sep 2018
NICE approves dabrafenib–trametinib for BRAF+ melanoma
5 Sep 2018
Kymriah® is set to become the first CAR-T therapy available on the NHS
29 Aug 2018
CAR-T therapy Yescarta get EU green light but meets resistance from NICE
21 Aug 2018 Drug development
Chinese regulators approve Alecensa® for NSCLC, hot on heels of FDA and EMA approvals
3 Aug 2018
FDA approves first-in-class treatment for rare adrenal tumors
17 May 2018
NICE approves atezolizumab for advanced bladder cancer patients on the NHS
21 Feb 2018 Drug development
Approval granted for novel non-small cell lung cancer drug
17 Jan 2018 Industry and business
Keytruda wows again; olaparib approval; CELESTIAL data: industry news round-up